Research output per year
Research output per year
Personal profile
Education/Academic qualification
Master, Master of Business Administration in Healthcare, University of Amsterdam
2016 → 2018
Award Date: 13 Apr 2018
PhD, Immunodiagnostics and immune surveillance in an era of evolving immunotherapeutic strategies in AML
2007 → 2011
Award Date: 29 Nov 2013
Master, Medicine, VU Medical School, Amsterdam
2001 → 2013
Award Date: 10 May 2013
External positions
Resident Clinical Chemistry, Department of Hematology and Clinical Chemistry Laboratories, OLVG, Oosterparkstraat 9, 1091 AC, Amsterdam
1 Nov 2013 → 31 Jul 2018
-
Direct sodium measurement prevents underestimation of hyponatremia in critically ill patients
van den Ancker, W., Haagen, I. A. & van der Voort, P. H. J., Mar 2015, In: Intensive care medicine. 41, 3, p. 553-4 2 p.Research output: Contribution to journal › Article › Academic › peer-review
13 Citations (Scopus) -
Actieve immuuntherapie bij acute myeloïde leukemie
Ruben, J. M., van den Ancker, W., Westers, T. M., Ossenkoppele, G. J., de Gruijl, T. D. & van de Loosdrecht, A. A., 2014, In: Nederlands Tijdschrift voor Hematologie. 11, 3, p. 91-99Research output: Contribution to journal › Article › Professional
-
Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines
Ruben, J. M., van den Ancker, W., Bontkes, H. J., Westers, T. M., Hooijberg, E., Ossenkoppele, G. J., de Gruijl, T. D. & van de Loosdrecht, A. A., 2014, In: Cancer immunology and immunotherapy. 63, 4, p. 335-345Research output: Contribution to journal › Article › Academic › peer-review
27 Citations (Scopus) -
Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia
van Luijn, M. M., van den Ancker, W., van Ham, S. M. & van de Loosdrecht, A. A., Dec 2014, In: Oncoimmunology. 3, 12, p. e941737 e941737.Research output: Contribution to journal › Article › Academic › peer-review
3 Citations (Scopus) -
High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemia
van den Ancker, W., van Luijn, M. M., Chamuleau, M. E. D., Kelder, A., Feller, N., Terwijn, M., Zevenbergen, A., Schuurhuis, G-J., Ham, S. M. V., Westers, T. M., Ossenkoppele, G. J. & van de Loosdrecht, A. A., 2014, In: Leukemia research. 38, 6, p. 691-693Research output: Contribution to journal › Article › Academic › peer-review
9 Citations (Scopus)